- Bacterial Infections 101 Pictures Slideshow
- Take the Tummy Trouble Quiz
- Hepatitis C Slideshow Pictures
Does Tygacil (tigecycline) cause side effects?
Tygacil (tigecycline) is an injectable antibiotic used to treat infections caused by susceptible bacteria. Tygacil is similar to tetracycline antibiotics and has activity against a large number of bacteria.
Tygacil is an antibiotic used to treat:
- complicated skin infections caused by susceptable strains of bacteria,
- complicated intra-abdominal infections caused by susceptible strains of bacteria, and
- community-aquired bacterial pneumonia.
Tygacil binds to bacterial ribosomes which produce the cell's proteins. The binding prevents bacterial ribosomes from producing important proteins needed for bacterial growth and multiplication. Tygacil prevents bacteria from multiplying, but it does not kill bacteria.
Common side effects of Tygacil include:
Other side effects of Tygacil include:
- injection site reactions (pain, swelling, and irritation),
- increased or decreased heart rate,
- increased sensitivity to sunlight, and
- permanent discoloration of teeth if used during tooth development (last half of pregnancy, infancy, and childhood to the age of 8 years).
Serious side effects of Tygacil include:
- alteration of normal bacteria in the colon that can lead to overgrowth of some bacteria such as Clostridium difficile, which causes inflammation of the colon (pseudomembranous colitis).
What are the important side effects of Tygacil (tigecycline)?
The most common side effects of tigecycline are diarrhea, nausea and vomiting. Nausea and vomiting is mild or moderate and usually occurs during the first two days of therapy.
Other side effects include:
- pain at the injection site;
- swelling and irritation;
- increased or decreased heart rate; and
Tigecycline is similar to tetracycline antibiotics and therefore may have similar side effects such as increased sensitivity to sunlight. Tigecycline may cause permanent discoloration of teeth if used during tooth development (last half of pregnancy, infancy, and childhood to the age of 8 years).
Like other antibiotics, tygecycline can alter normal bacteria in the colon and encourage overgrowth of some bacteria such as Clostridium difficile, which causes inflammation of the colon (pseudomembranous colitis). Patients who develop signs of pseudomembranous colitis after starting tigecycline (diarrhea, fever, abdominal pain, and possibly shock) should contact their physician immediately.
Tygacil (tigecycline) side effects list for healthcare professionals
The following serious adverse reactions are described elsewhere in the labeling:
- All-Cause Mortality
- Mortality Imbalance and Lower Cure Rates in Hospital-Acquired Pneumonia
- Hepatic Adverse Effects
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In clinical trials, 2514 patients were treated with Tygacil. Tygacil was discontinued due to adverse reactions in 7% of patients compared to 6% for all comparators. Table 1 shows the incidence of adverse reactions through test of cure reported in ≥2% of patients in these trials.
Table 1. Incidence (%) of Adverse Reactions Through Test of Cure Reportedin≥ 2% of Patients Treated in Clinical Studies
|Body as a Whole|
|Hemic and Lymphatic System|
|Metabolic and Nutritional|
|Alkaline Phosphatase Increased||3||3|
|Skin and Appendages|
|a Vancomycin/Aztreonam, Imipenem/Cilastatin, Levofloxacin, Linezolid.|
b LFT abnormalities in Tygacil-treated patients were reported more frequently in the post therapy period than those in comparator-treated patients, which occurred more often on therapy.
In all 13 Phase 3 and 4 trials that included a comparator, death occurred in 4.0% (150/3788) of patients receiving Tygacil and 3.0% (110/3646) of patients receiving comparator drugs. In a pooled analysis of these trials, based on a random effects model by trial weight, an adjusted risk difference of all-cause mortality was 0.6% (95% CI 0.1, 1.2) between Tygacil and comparator-treated patients (see Table 2). The cause of the imbalance has not been established. Generally, deaths were the result of worsening infection, complications of infection or underlying co-morbidities.
Table 2. Patients with Outcome of Death by Infection Type
|Infection Type||Tygacil||Comparator||Risk Difference* % (95% CI)|
|cSSSI||12/834||1.4||6/813||0.7||0.7 (-0.3, 1.7)|
|cIAI||42/1382||3.0||31/1393||2.2||0.8 (-0.4, 2.0)|
|CAP||12/424||2.8||11/422||2.6||0.2 (-2.0, 2.4)|
|HAP||66/467||14.1||57/467||12.2||1.9 (-2.4, 6.3)|
|Non-VAPa||41/336||12.2||42/345||12.2||0.0 (-4.9, 4.9)|
|VAPa||25/131||19.1||15/122||12.3||6.8 (-2.1, 15.7)|
|RP||11/128||8.6||2/43||4.7||3.9 (-4.0, 11.9)|
|DFI||7/553||1.3||3/508||0.6||0.7 (-0.5, 1.8)|
|Overall Adjusted||150/3788||4.0||110/3646||3.0||0.6 (0.1, 1.2)**|
|CAP = Community-acquired pneumonia; cIAI = Complicated intra-abdominal infections; cSSSI = Complicated skin and skin structure infections; HAP = Hospital-acquired pneumonia; VAP = Ventilator-associated pneumonia; RP = Resistant pathogens; DFI = Diabetic foot infections.|
* The difference between the percentage of patients who died in Tygacil and comparator treatment groups. The 95% CI for each infection type was calculated using the normal approximation method without continuity correction.
** Overall adjusted (random effects model by trial weight) risk difference estimate and 95% CI.
a These are subgroups of the HAP population.
Note: The studies include 300, 305, 900 (cSSSI), 301, 306, 315, 316, 400 (cIAI), 308 and 313 (CAP), 311 (HAP), 307 [Resistant gram-positive pathogen study in patients with MRSA or Vancomycin-Resistant Enterococcus (VRE)], and 319 (DFI with and without osteomyelitis).
An analysis of mortality in all trials conducted for approved indications -cSSSI, cIAI, and CABP, including post-market trials (one in cSSSI and two in cIAI) -showed an adjusted mortality rate of 2.5% (66/2640) for tigecycline and 1.8% (48/2628) for comparator, respectively. The adjusted risk difference for mortality stratified by trial weight was 0.6% (95% CI 0.0, 1.2).
In comparative clinical studies, infection-related serious adverse reactions were more frequently reported for subjects treated with Tygacil (7%) versus comparators (6%). Serious adverse reactions of sepsis/septic shock were more frequently reported for subjects treated with Tygacil (2%) versus comparators (1%). Due to baseline differences between treatment groups in this subset of patients, the relationship of this outcome to treatment cannot be established.
The most common adverse reactions were nausea and vomiting which generally occurred during the first 1 – 2 days of therapy. The majority of cases of nausea and vomiting associated with Tygacil and comparators were either mild or moderate in severity. In patients treated with Tygacil, nausea incidence was 26% (17% mild, 8% moderate, 1% severe) and vomiting incidence was 18% (11% mild, 6% moderate, 1% severe).
In patients treated for complicated skin and skin structure infections (cSSSI), nausea incidence was 35% for Tygacil and 9% for vancomycin/aztreonam; vomiting incidence was 20% for Tygacil and 4% for vancomycin/aztreonam. In patients treated for complicated intra-abdominal infections (cIAI), nausea incidence was 25% for Tygacil and 21% for imipenem/cilastatin; vomiting incidence was 20% for Tygacil and 15% for imipenem/cilastatin. In patients treated for community-acquired bacterial pneumonia (CABP), nausea incidence was 24% for Tygacil and 8% for levofloxacin; vomiting incidence was 16% for Tygacil and 6% for levofloxacin.
Discontinuation from Tygacil was most frequently associated with nausea (1%) and vomiting (1%). For comparators, discontinuation was most frequently associated with nausea (<1%).
The following adverse reactions were reported (<2%) in patients receiving Tygacil in clinical studies:
Special Senses: taste perversion
Hemic and Lymphatic System: prolonged activated partial thromboplastin time (aPTT), prolonged prothrombin time (PT), eosinophilia, increased international normalized ratio (INR), thrombocytopenia
Skin and Appendages: pruritus
The following adverse reactions have been identified during post-approval use of Tygacil. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish causal relationship to drug exposure.
What drugs interact with Tygacil (tigecycline)?
Prothrombin time or other suitable anticoagulation test should be monitored if Tygacil is administered with warfarin.
Concurrent use of antibacterial drugs with oral contraceptives may render oral contraceptives less effective.
Multimedia: Slideshows, Images & Quizzes
Appendicitis: Symptoms, Signs, Causes, Appendectomy in Detail
What causes appendicitis? What causes a burst or ruptured appendix? Learn step-by-step what happens during laparoscopic...
Diverticulitis (Diverticulosis) Symptoms, Diet, Treatment
Diverticulitis (diverticulosis) is a condition in which the diverticulum or diverticula rupture in the colon, causing infection....
Do I Have Pneumonia Quiz
Pneumonia can be deadly. Take the Pneumonia Quiz on MedicineNet to learn more about this highly contagious, infectious disease.
Pancreatitis Quiz: Test Your Medical IQ
What does the pancreas do, and what happens in the body that causes pancreatitis? Test your medical IQ of pancreatitis with this...
Appendicitis Quiz: Test Your Medical IQ
How dangerous is appendicitis? Take this quiz to answer questions, get quick facts, and learn the causes of appendicitis as well...
Picture of Diverticulitis
Diverticula can be seen via barium x-ray (barium enema). See a picture of Diverticulitis and learn more about the health topic.
Picture of Appendicitis
Inflammation of the appendix, the small worm-like projection from the first part of the colon. See a picture of Appendicitis and...
Related Disease Conditions
Appendicitis is an inflammation of the appendix. Appendicitis often causes sings and symptoms such as abdominal pain in the lower right quadrant, nausea, vomiting, abdominal tenderness, fever, and loss of appetite. Delay in surgery can result in appendix rupture with potentially serious complications.
Diverticulitis (Diverticulosis, Diverticular Disease)
Most people with diverticulosis have few if any symptoms at all. When people do experience signs and symptoms of diverticulosis (diverticular disease) they may include abdominal pain, abdominal cramps, diarrhea, constipation, and bloating. Diverticulitis is a condition in which diverticuli in the colon rupture. The rupture results in infection in the tissues that surround the colon. Treatment methods for diverticulitis includes prescription medications, and in some cases, diverticulitis surgery.
Pneumonia is inflammation of the lungs caused by fungi, bacteria, or viruses. Symptoms and signs include cough, fever, shortness of breath, and chills. Antibiotics treat pneumonia, and the choice of the antibiotic depends upon the cause of the infection.
Acute and Chronic Pancreatitis
Pancreatitis is a rare disease in which the pancreas becomes inflamed. There are two types of pancreatitis: acute and chronic. Symptoms of pancreatitis include abdominal pain, fever, nausea, vomiting, and a rapid pulse. Treatment of pancreatitis often requires hospitalization.
Is Pneumonia Contagious?
Pneumonia is inflammation of the lung usually caused by bacterial or viral infection (rarely, also by fungi) that causes the air sacs to fill with pus. If inflammation affects both lungs, the infection is termed double pneumonia. If it affects one lung, it is termed single pneumonia. If it affects only a certain lobe of a lung it's termed lobar pneumonia. Most pneumonias are caused by bacteria and viruses, but some pneumonias are caused by inhaling toxic chemicals that damage lung tissue.
Peritonitis is a bacterial infection inside of the abdomen. Some doctors choose to group the causes of peritonitis into five categories; 1) primary peritonitis, 2) secondary peritonitis, 3) tertiary peritonitis, 4) chemical (sterile) peritonitis, and 5) peritoneal abscess. Others do not categorize peritonitis, they use a term to describe the disease in front or behind the word peritonitis. Symptoms include diarrhea, abdominal pain, nausea, and vomiting. Treatment is generally with antibiotics.
Second Source article from WebMD
Second Source article from Government
Second Source WebMD Medical Reference
Second Source article from Government
Primary Sclerosing Cholangitis (PSC)
Primary sclerosing cholangitis or PSC is a disease of the liver. The cause of PSC is not known. Symptoms may include itching, fatigue, jaundice, fever, and confusion. The only treatment for Primary sclerosing cholangitis is a liver transplant.
Interstitial Lung Disease (Interstitial Pneumonia)
Interstitial lung disease refers to a variety of diseased that thicken the tissue between the lungs' air sacks. Symptoms of interstitial lung disease include shortness of breath, cough, and vascular problems, and their treatment depends on the underlying cause of the tissue thickening. Causes include viruses, bacteria, tobacco smoke, environmental factors, cancer, and heart or kidney failure.
Is Diverticulitis Contagious?
Diverticulitis is an inflammation of the diverticula or diverticulum. Diverticulitis causes are either infectious or noninfectious, however, it is not contagoius. Symptoms of diverticulitis include: nausea, vomiting, diarrhea, gas, constipation, changes in bowel habits, bloating, constipation, fever, abdominal tenderness, swollen abdomen, fistula formation, and lower left abdominal pain.
Treatment & Diagnosis
- Pneumonia FAQs
- Appendicitis FAQs
- Pancreatitis FAQs
- Pneumonia Vaccination: Who Should Have One?
- Appendicitis: Is It Appendicitis or Something Else?
- Primary Sclerosing Cholangitis -- Walter Payton's Disease
- Pneumonia ... Quick New Urine Test
- Payton, Bile Duct Cancer & Sclerosing Cholangitis
- Ashcroft Surgery for Gallstone Pancreatitis
- Appendicitis Test - Approved by FDA
- What Is an ERCP Procedure For Pancreatitis?
- How Serious Is Pancreatitis?
- Can MRI Find Pancreatic Duct Stones?
- Should I Get the Pneumonia Vaccine Every Year?
- Should I Avoid Nuts if I Have Diverticulitis?
- How Long Is Pneumonia Contagious?
- Pneumonia Symptoms
- Appendicitis Treatment with Antibiotics
- Pneumonia Treatment
- Pneumonia vs. Walking Pneumonia
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.